Atom Investors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Atom Investors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,183	Closed	-$266K	–	861
2025 Q4	$266K	Sell	2,183 -119,886	-98%	-$13.7M	0.02%	460
2025 Q3	$12.2M	Buy	122,069 +38,005	+45%	+$3.42M	0.93%	9
2025 Q2	$6.97M	Buy	84,064 +21,580	+35%	+$1.72M	0.62%	28
2025 Q1	$5.07M	Sell	62,484 -11,708	-16%	-$1.05M	0.62%	36
2024 Q4	$6.68M	Buy	74,192 +39,417	+113%	+$3.82M	0.83%	13
2024 Q3	$3.44M	Sell	34,775 -65,681	-65%	-$6.45M	0.36%	94
2024 Q2	$9.31M	Buy	100,456 +9,565	+11%	+$858K	0.93%	14
2024 Q1	$8.62M	Buy	90,891 +64,463	+244%	+$5.98M	1.08%	5
2023 Q4	$2.36M	Buy	26,428 +5,626	+27%	+$418K	0.42%	74
2023 Q3	$1.52M	Sell	20,802 -13,233	-39%	-$1.06M	0.35%	89
2023 Q2	$2.83M	Sell	34,035 -98,716	-74%	-$8.26M	1.08%	14
2023 Q1	$10.1M	Sell	132,751 -77,531	-37%	-$6.43M	5.5%	2
2022 Q4	$17.5M	Buy	210,282 +54,533	+35%	+$4.41M	8.72%	1
2022 Q3	$12.4M	Sell	155,749 -43,415	-22%	-$3.66M	4.35%	1
2022 Q2	$14.8M	Buy	199,164 +45,276	+29%	+$3.4M	6.47%	2
2022 Q1	$13.8M	Sell	153,888 -157,281	-51%	-$14.5M	6.47%	3
2021 Q4	$34.8M	Sell	311,169 -4,685	-1%	-$565K	5.84%	5
2021 Q3	$39.7M	Buy	315,854 +53,021	+20%	+$6.83M	3.21%	5
2021 Q2	$35.6M	Buy	+262,833	New	+$34.6M	4.48%	5
2020 Q4	–	Sell	-2,082	Closed	-$267K	–	594
2020 Q3	$232K	Buy	+2,082	New	+$233K	0.02%	323
2019 Q2	–	Sell	-128,914	Closed	-$11.7M	–	642
2019 Q1	$11.7M	Buy	+128,914	New	+$11M	0.99%	20

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Atom Investors's XBI Position: Q1 2026 in Review

Atom Investors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 2,183 shares — an estimated $266K sold.

Atom Investors first reported a position in XBI in Q1 2019 and held it in 21 quarters. The position peaked at $39.7M in Q3 2021. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Atom Investors reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
Atom Investors sold 2,183 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $266K.
Atom Investors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 21 quarters.
Atom Investors's State Street SPDR S&P Biotech ETF position peaked at $39.7M in Q3 2021.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.